Please use this identifier to cite or link to this item: https://repositorio.uca.edu.ar/handle/123456789/9889
Título : Treatments used for obsessive-compulsive disorder : an international perspective
Autor : Brakoulias, Vlasios 
Starcevic, Vladan 
Albert, Umberto 
Arumugham, Shyam Sundar 
Bailey, Brenda E. 
Belloch, Amparo 
Borda, Tania 
Dell'Osso, Liliana 
Elias, Jason A. 
Falkenstein, Martha J. 
Ferrao, Ygor A. 
Fontenelle, Leonardo F. 
Jelinek, Lena 
Kalogeraki, Leto 
Kay, Brian 
Laurito, Luana D. 
Lochner, Christine 
Maina, Giuseppe 
Marazziti, Donatella 
Martin, Andrew 
Matsunaga, Hisato 
Miguel, Eurípedes C. 
Morgado, Pedro 
Mourikis, Irakis 
Pasquini, Massimo 
Perez Rivera, Rodrigo 
Potluri, Sriramya 
Reddy, Janardhan Y. C. 
Riemann, Brian C. 
do Rosario, Maria Conceição 
Shavitt, Roseli G. 
Stein, Dan J. 
Viswasam, Kirupumani 
Wang, Zhen 
Fineberg, Naomi A. 
Palabras clave : TERAPIA PSICOANALITICABENZODIAZEPINASANTIPSICOTICOSTRASTORNO OBSESIVO COMPULSIVOFARMACOTERAPIASEROTONINAPSICOFARMACOLOGIAPSICOTROPICOS
Fecha de publicación : 2019
Editorial : Wiley
Cita : Brakoulias, V. Treatments used for obsessive-compulsive disorder : an international perspective [En línea]. Human Psychopharmacology: Clinical & Experimental. 2019, 34(1). doi:10.1002/hup.2686 Disponible en: https://repositorio.uca.edu.ar/handle/123456789/9889
Resumen : Abstract: Objective: The objective of this study was to characterise international trends in the use of psychotropic medication, psychological therapies, and novel therapies used to treat obsessive–compulsive disorder (OCD). Methods: Researchers in the field of OCD were invited to contribute summary statistics on the characteristics of their samples. Consistency of summary statistics across countries was evaluated. Results: The study surveyed 19 expert centres from 15 countries (Argentina, Australia, Brazil, China, Germany, Greece, India, Italy, Japan, Mexico, Portugal, South Africa, Spain, the United Kingdom, and the United States) providing a total sample of 7,340 participants. Fluoxetine (n = 972; 13.2%) and fluvoxamine (n = 913; 12.4%) were the most commonly used selective serotonin reuptake inhibitor medications. Risperidone (n = 428; 7.3%) and aripiprazole (n = 415; 7.1%) were the most commonly used antipsychotic agents. Neurostimulation techniques such as transcranial magnetic stimulation, deep brain stimulation, gamma knife surgery, and psychosurgery were used in less than 1% of the sample. There was significant variation in the use and accessibility of exposure and response prevention for OCD. Conclusions: The variation between countries in treatments used for OCD needs further evaluation. Exposure and response prevention is not used as frequently as guidelines suggest and appears difficult to access in most countries. Updated treatment guidelines are recommended.
URI : https://repositorio.uca.edu.ar/handle/123456789/9889
ISSN : 0885-6222 (impreso)
1099-1077 (online)
Disciplina: PSICOLOGIA
DOI: 10.1002/hup.2686
Derechos: Acceso abierto
Appears in Collections:Artículos

Files in This Item:
File Description SizeFormat
treatments-used-obsessive-compulsive.pdf573,79 kBAdobe PDFThumbnail
View/Open
Show full item record

Page view(s)

44
checked on Mar 3, 2021

Download(s)

205
checked on Mar 3, 2021

Google ScholarTM

Check


Altmetric


This item is licensed under a Creative Commons License Creative Commons